Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet.

Comella P, Casaretti R, Manzo R, Sandomenico C, Licenziato M, Avallone A, Franco L; Southern Italy Cooperative Oncology Group Investigators.

Acta Oncol. 2010;49(1):50-6. doi: 10.3109/02841860903369540.

PMID:
20100144
2.

Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.

Comella P, Massidda B, Filippelli G, Farris A, Natale D, Barberis G, Maiorino L, Palmeri S, Cannone M, Condemi G; Southern Italy Cooperative Oncology Group.

J Cancer Res Clin Oncol. 2009 Feb;135(2):217-26. doi: 10.1007/s00432-008-0454-7. Epub 2008 Aug 22.

PMID:
18719941

Supplemental Content

Loading ...
Support Center